Cingulate to Present at H.C. Wainwright Global Investment Conference
May 18 2022 - 5:20PM
Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical
company utilizing its proprietary Precision Timed Release™ (PTR™)
drug delivery platform technology to build and advance a pipeline
of next-generation pharmaceutical products, today announced that
Chairman and Chief Executive Officer, Shane J. Schaffer, and Chief
Medical Officer, Matthew Brams, M.D., will present a company
overview at the H.C. Wainwright Global Investment Conference on
Wednesday, May 25, 2022, from 3:00-3:30 p.m. ET, at the
Fontainebleau Miami Beach Hotel, Miami, FL.
A live webcast of the presentation may be accessed at: HCW -
Cingulate Live Presentation. A replay will be available on the
investor section of Cingulate’s website at Cingulate Events &
Presentations for 90 days.
About Cingulate®Cingulate Inc. (NASDAQ: CING),
is a clinical-stage biopharmaceutical company utilizing its
proprietary Precision Timed Release™ (PTR™) drug delivery platform
technology to build and advance a pipeline of next-generation
pharmaceutical products, designed to improve the lives of patients
suffering from frequently diagnosed conditions characterized by
burdensome daily dosing regimens and suboptimal treatment outcomes.
With an initial focus on the treatment of Attention
Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and
evaluating additional therapeutic areas where PTR technology may be
employed to develop future product candidates, such as anxiety
disorders.
Cingulate is headquartered in Kansas City, KS. For more
information visit Cingulate.com
Investor Relations Thomas DaltonHead of
Investor & Public Relations, Cingulate, Inc.(913)
942-2301TDalton@cingulate.com
Matt KrepsDarrow Associates(214) 597-8200mkreps@darrowir.com
Media RelationsMelyssa WeibleElixir Health
Public Relations(201) 723-5805mweible@elixirhealthpr.com
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cingulate (NASDAQ:CING)
Historical Stock Chart
From Jul 2023 to Jul 2024